NERV
Income statement / Annual
Last year (2024), Minerva Neurosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Minerva Neurosciences, Inc.'s net income was $1.44 M.
See Minerva Neurosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$41.18 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$30,982.00
|
$8,513.00
|
$101,786.00
|
$0.00
|
$161,507.00
|
$17,467.00
|
$11,094.00
|
$16,530.00
|
$17,276.00
|
| Gross Profit |
$0.00
|
-$30,982.00
|
-$8,513.00
|
-$101,786.00
|
$41.18 M
|
-$161,507.00
|
-$17,467.00
|
-$11,094.00
|
-$16,530.00
|
-$17,276.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$11.90 M
|
$12.71 M
|
$14.65 M
|
$32.04 M
|
$22.04 M
|
$58.12 M
|
$34.89 M
|
$30.26 M
|
$20.44 M
|
$18.53 M
|
| General & Administrative Expenses |
$9.95 B
|
$10.41 B
|
$10.58 M
|
$13.33 M
|
$17.29 M
|
$17.74 M
|
$16.84 M
|
$10.91 M
|
$9.75 M
|
$7.58 M
|
| Selling & Marketing Expenses |
-$9.94 B
|
-$10.40 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.95 M
|
$10.38 M
|
$10.58 M
|
$13.33 M
|
$17.29 M
|
$17.74 M
|
$16.84 M
|
$10.91 M
|
$9.75 M
|
$7.58 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$21.85 M
|
$23.09 M
|
$25.23 M
|
$45.37 M
|
$39.33 M
|
$75.86 M
|
$51.73 M
|
$41.17 M
|
$30.19 M
|
$26.11 M
|
| Cost And Expenses |
$21.85 M
|
$23.12 M
|
$25.23 M
|
$45.37 M
|
$39.33 M
|
$75.86 M
|
$51.73 M
|
$41.17 M
|
$30.19 M
|
$26.11 M
|
| Interest Income |
$0.00
|
$1.44 M
|
$556,946.00
|
$16,516.00
|
$161,207.00
|
$1.46 M
|
$1.67 M
|
$941,833.00
|
$198,000.00
|
$96,910.00
|
| Interest Expense |
$4.56 M
|
$8.28 M
|
$7.41 M
|
$6.33 M
|
$0.00
|
$0.00
|
$110,448.00
|
$614,264.00
|
$1.03 M
|
$1.05 M
|
| Depreciation & Amortization |
-$21.83 B
|
$30,982.00
|
$8,513.00
|
$101,786.00
|
$176,177.00
|
$161,507.00
|
$17,467.00
|
$11,094.00
|
$16,530.00
|
$17,276.00
|
| EBITDA |
-$21.85 B |
-$21.69 M |
-$24.69 M |
-$51.61 M |
$1.93 M |
-$74.28 M |
-$50.04 M |
-$40.27 M |
-$30.00 M |
-$26.01 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0.05
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0.04
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.46 B
|
-$6.89 M
|
-$6.88 M
|
-$6.34 M
|
$94,024.00
|
-$17.57 M
|
$1.56 M
|
$270,682.00
|
-$854,676.00
|
-$972,013.00
|
| Income Before Tax |
$1.44 B
|
-$30.01 M
|
-$32.11 M
|
-$51.71 M
|
$1.94 M
|
-$74.44 M
|
-$50.17 M
|
-$40.90 M
|
-$31.05 M
|
-$27.08 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0.05
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
-$2.00
|
$6.88 M
|
-$1.80 M
|
-$94,024.00
|
-$2.25 M
|
$1.67 M
|
-$9.38 M
|
$1.03 M
|
$1.05 M
|
| Net Income |
$1.44 M
|
-$30.01 M
|
-$38.99 M
|
-$49.91 M
|
$1.94 M
|
-$72.18 M
|
-$50.17 M
|
-$31.52 M
|
-$31.05 M
|
-$27.08 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0.05
|
0
|
0
|
0
|
0
|
0
|
| EPS |
0.19 |
-4.61 |
-7.3 |
-9.35 |
0.38 |
-14.8 |
-10.35 |
-6.65 |
-7.88 |
-9.25 |
| EPS Diluted |
0.19 |
-4.61 |
-7.3 |
-9.35 |
0.38 |
-14.8 |
-10.35 |
-6.65 |
-7.88 |
-9.25 |
| Weighted Average Shares Out |
$7.57 M
|
$6.51 M
|
$5.34 M
|
$5.34 M
|
$5.10 M
|
$4.88 M
|
$4.85 M
|
$4.74 M
|
$3.94 M
|
$2.93 M
|
| Weighted Average Shares Out Diluted |
$7.57 M
|
$6.51 M
|
$5.34 M
|
$5.34 M
|
$5.11 M
|
$4.88 M
|
$4.85 M
|
$4.74 M
|
$3.94 M
|
$2.93 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
